Your browser doesn't support javascript.
loading
Health-related quality of life assessment for patients with advanced or metastatic renal cell carcinoma treated with a tyrosine kinase inhibitor using electronic patient-reported outcomes in daily clinical practice (QUANARIE trial): study protocol.
Mouillet, Guillaume; Fritzsch, Joëlle; Paget-Bailly, Sophie; Pozet, Astrid; Es-Saad, Ikram; Meurisse, Aurelia; Vernerey, Dewi; Mouyabi, Kristina; Berthod, Diane; Bonnetain, Franck; Anota, Amélie; Thiery-Vuillemin, Antoine.
Afiliación
  • Mouillet G; Department of Medical Oncology, University Hospital of Besançon, Boulevard Fleming, F-25000, Besançon, France. gmouillet@chu-besancon.fr.
  • Fritzsch J; Methodological and Quality of Life Unit, University Hospital of Besançon, F-25000, Besançon, France. gmouillet@chu-besancon.fr.
  • Paget-Bailly S; INSERM, EFS BFC, UMR1098, Interactions Hôte-Greffon-Tumeur/Ingénierie Cellulaire et Génique, University Bourgogne Franche-Comté, F-25000, Besançon, France. gmouillet@chu-besancon.fr.
  • Pozet A; Methodological and Quality of Life Unit, University Hospital of Besançon, F-25000, Besançon, France.
  • Es-Saad I; INSERM, EFS BFC, UMR1098, Interactions Hôte-Greffon-Tumeur/Ingénierie Cellulaire et Génique, University Bourgogne Franche-Comté, F-25000, Besançon, France.
  • Meurisse A; Methodological and Quality of Life Unit, University Hospital of Besançon, F-25000, Besançon, France.
  • Vernerey D; INSERM, EFS BFC, UMR1098, Interactions Hôte-Greffon-Tumeur/Ingénierie Cellulaire et Génique, University Bourgogne Franche-Comté, F-25000, Besançon, France.
  • Mouyabi K; Methodological and Quality of Life Unit, University Hospital of Besançon, F-25000, Besançon, France.
  • Berthod D; INSERM, EFS BFC, UMR1098, Interactions Hôte-Greffon-Tumeur/Ingénierie Cellulaire et Génique, University Bourgogne Franche-Comté, F-25000, Besançon, France.
  • Bonnetain F; Methodological and Quality of Life Unit, University Hospital of Besançon, F-25000, Besançon, France.
  • Anota A; INSERM, EFS BFC, UMR1098, Interactions Hôte-Greffon-Tumeur/Ingénierie Cellulaire et Génique, University Bourgogne Franche-Comté, F-25000, Besançon, France.
  • Thiery-Vuillemin A; Methodological and Quality of Life Unit, University Hospital of Besançon, F-25000, Besançon, France.
Health Qual Life Outcomes ; 17(1): 25, 2019 Feb 04.
Article en En | MEDLINE | ID: mdl-30717745
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Pirimidinas / Calidad de Vida / Sulfonamidas / Carcinoma de Células Renales / Inhibidores de Proteínas Quinasas / Sunitinib / Neoplasias Renales Tipo de estudio: Clinical_trials / Guideline / Observational_studies / Prognostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Health Qual Life Outcomes Asunto de la revista: SAUDE PUBLICA Año: 2019 Tipo del documento: Article País de afiliación: Francia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Pirimidinas / Calidad de Vida / Sulfonamidas / Carcinoma de Células Renales / Inhibidores de Proteínas Quinasas / Sunitinib / Neoplasias Renales Tipo de estudio: Clinical_trials / Guideline / Observational_studies / Prognostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Health Qual Life Outcomes Asunto de la revista: SAUDE PUBLICA Año: 2019 Tipo del documento: Article País de afiliación: Francia